pooled analysis of outcomes from 1st line treatment for metastatic colorectal cancer

pooled analysis of outcomes from 1st line treatment for metastatic colorectal cancer - Evaluation of first-line treatment for Metastatic colorectal cancer, Especially Resection of liver metastasis and Long survival, in Japanese Database.(EMERaLD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006392

Enrollment

1000

Registered

2011-09-22

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) With first line treatment including oxaliplatin and bevacizumab for metastatic colorectal canncer 2)Treatment-Initiated after January, 2010 3) Radiologically assessed during first line treatment 4) Monitored by laboratory test and symptom check during first line treatment 5)able to provide observation data to this study

Exclusion criteria

Exclusion criteria: reservation

Design outcomes

Primary

Measure	Time frame
Overall survival, liver resection rate, R0 liver resection rate	—

Secondary

Measure	Time frame
Response rate, Progression free survival, Safety, sub-group analysis (regimen specific, Kras status specific, etc)	—

Countries

Japan

Contacts

Public ContactAkita Yamao

Public Health Research Foundation Comprehensive Support Project for Clinical Research

cspor-office@csp.or.jp03-5287-2636

Outcome results